These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16119297)

  • 1. [Reimbursement policy for ambulatory treatment of pediatric infections with ceftriaxone].
    Krahenbuhl JD; Di Paolo E; Steiner S; Gehri M
    Rev Med Suisse; 2005 Jul; 1(27):1814-5. PubMed ID: 16119297
    [No Abstract]   [Full Text] [Related]  

  • 2. Appropriate selection of antimicrobials in the treatment of ambulatory patients.
    Goetz MB
    Health Syst Lead; 1994 Oct; 1(8):34-8. PubMed ID: 10140124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ceftriaxone in the ambulatory treatment of bacterial infections].
    Santa Cruz Valverde PL; Cruz Abascal R
    Med Clin (Barc); 1993 May; 100(18):718. PubMed ID: 8492604
    [No Abstract]   [Full Text] [Related]  

  • 4. Ambulatory treatment with intramuscular ceftriaxone.
    Schlaeffer F
    J Chemother; 1989 Jul; 1(4 Suppl):655-6. PubMed ID: 16312577
    [No Abstract]   [Full Text] [Related]  

  • 5. Are we finally ready for outpatient management of febrile neutropenia?
    Saini S; Rosoff PM
    Pediatr Blood Cancer; 2007 Nov; 49(6):765-6. PubMed ID: 17514730
    [No Abstract]   [Full Text] [Related]  

  • 6. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Reimbursement.
    Tierce JC
    Hosp Pract (Off Ed); 1993 Jun; 28 Suppl 1():44-51. PubMed ID: 8505398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pediatric bacterial meningitis with a 7-day regimen of once-daily ceftriaxone injections. Multicentre study carried out in non-university pediatric departments in the French and Italian-speaking regions of Switzerland.
    Renevey F; Martin E; Fröscher F; Reusser P
    J Chemother; 1989 Jul; 1(4 Suppl):678-9. PubMed ID: 16312589
    [No Abstract]   [Full Text] [Related]  

  • 8. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial of ceftriaxone in different bacterial infections.
    Kavakas H; Ellinas C; Matzakos K; Politikou L; Sahin A
    J Chemother; 1989 Jul; 1(4 Suppl):658-9. PubMed ID: 16312579
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of orthopedic infections with ceftriaxone.
    Höckel S
    J Chemother; 1989 Jul; 1(4 Suppl):734. PubMed ID: 16312613
    [No Abstract]   [Full Text] [Related]  

  • 11. Outpatient treatment of serious infections in infants and children with ceftriaxone.
    Powell KR; Mawhorter SD
    J Pediatr; 1987 Jun; 110(6):898-901. PubMed ID: 3585606
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia.
    Bhavnani SM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):59-64. PubMed ID: 17889491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple and more cost-effective antibiotic regimen for perforated appendicitis.
    St Peter SD; Little DC; Calkins CM; Murphy JP; Andrews WS; Holcomb GW; Sharp RJ; Snyder CL; Ostlie DJ
    J Pediatr Surg; 2006 May; 41(5):1020-4. PubMed ID: 16677904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial diarrheas and antibiotics: European recommendations].
    Gendrel D; Cohen R; ;
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S93-6. PubMed ID: 19000862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of ceftriaxone (1 g single dose) versus cefotaxime (three 1 g doses) for gynecologic and obstetric infections.
    Gerstner GJ
    J Chemother; 1989 Jul; 1(4 Suppl):884-6. PubMed ID: 16312686
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost considerations in the treatment of paediatric infections.
    Steele RW
    S Afr Med J; 1987 Jun; Suppl 2():7-9. PubMed ID: 3603258
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities.
    Alekwe LO; Kuti O; Orji EO; Ogunniyi SO
    J Matern Fetal Neonatal Med; 2008 Sep; 21(9):638-42. PubMed ID: 18828055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope.
    Allon M
    Am J Kidney Dis; 2008 Feb; 51(2):165-8. PubMed ID: 18215693
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate ceftriaxone use in the emergency department of a tertiary hospital in Melbourne, Australia.
    Xie C; Charles PG; Urbancic K
    Emerg Med Australas; 2013 Feb; 25(1):94-6. PubMed ID: 23379463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.